Britta Flach

11.6k total citations
14 papers, 152 citations indexed

About

Britta Flach is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Britta Flach has authored 14 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Britta Flach's work include HIV Research and Treatment (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and T-cell and B-cell Immunology (4 papers). Britta Flach is often cited by papers focused on HIV Research and Treatment (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and T-cell and B-cell Immunology (4 papers). Britta Flach collaborates with scholars based in United States, Germany and United Kingdom. Britta Flach's co-authors include M. Juliana McElrath, Miranda S. Moore, Stephen C. De Rosa, Harlan Robins, Paul Spearman, Alan Aderem, Jonathan A. Perkins, Frank Schmitz, Georgia D. Tomaras and Antje Heit and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Britta Flach

10 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Britta Flach United States	5	85	47	34	30	24	14	152
Kerri G. Lal United States	6	188 2.2×	36 0.8×	21 0.6×	34 1.1×	28 1.2×	9	216
Bénédict Fallet Switzerland	6	148 1.7×	48 1.0×	57 1.7×	27 0.9×	14 0.6×	11	236
Sarah E. Mahl United States	3	191 2.2×	44 0.9×	38 1.1×	27 0.9×	22 0.9×	3	244
David Ng’ang’a United States	5	49 0.6×	24 0.5×	45 1.3×	28 0.9×	24 1.0×	5	115
Matt Liu United States	4	70 0.8×	37 0.8×	27 0.8×	53 1.8×	7 0.3×	5	153
Dhilshan Jayasinghe Australia	7	78 0.9×	30 0.6×	31 0.9×	27 0.9×	12 0.5×	11	139
Wayne Paes United Kingdom	8	76 0.9×	34 0.7×	21 0.6×	33 1.1×	19 0.8×	14	150
Dimana Dimitrova United States	8	62 0.7×	30 0.6×	35 1.0×	13 0.4×	9 0.4×	26	135
Mathieu Claireaux Netherlands	6	91 1.1×	37 0.8×	33 1.0×	12 0.4×	43 1.8×	15	142
Alexander Muselman United States	3	114 1.3×	38 0.8×	26 0.8×	16 0.5×	9 0.4×	5	171

Countries citing papers authored by Britta Flach

Since Specialization

Citations

This map shows the geographic impact of Britta Flach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Flach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Flach more than expected).

Fields of papers citing papers by Britta Flach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Flach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Flach. The network helps show where Britta Flach may publish in the future.

Co-authorship network of co-authors of Britta Flach

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Flach. A scholar is included among the top collaborators of Britta Flach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Flach. Britta Flach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wojcechowskyj, Jason A., et al.. (2025). Controlling reactogenicity while preserving immunogenicity from a self-amplifying RNA vaccine by modulating nucleocytoplasmic transport. npj Vaccines. 10(1). 85–85. 3 indexed citations

Dionne‐Odom, Jodie, James D. Campbell, Robert L. Atmar, et al.. (2025). Baptism in a Pandemic: Infectious Diseases Clinical Research Consortium Network Design for Readiness and Response. Clinical Infectious Diseases. 81(Supplement_2). S109–S116.

Huang, Ying, Erica Andersen‐Nissen, Lindsay N. Carpp, et al.. (2024). Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses. Viruses. 16(9). 1365–1365.

Dintwe, One, Stephen C. De Rosa, Yunda Huang, et al.. (2022). Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses. Journal of Leukocyte Biology. 112(5). 1167–1181.

Prabhakaran, Madhu, Sandeep Narpala, Sarah F. Andrews, et al.. (2021). A sensitive method to quantify HIV-1 antibodies in mucosal samples. Journal of Immunological Methods. 491. 112995–112995. 4 indexed citations

O’Connell, Sarah, Tammy Armbrust, Sandeep Narpala, et al.. (2021). Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2. ImmunoHorizons. 5(6). 466–476. 22 indexed citations

Li, Jerry, Mina Nikanjam, Coleen K. Cunningham, et al.. (2020). Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach. Clinical Pharmacology & Therapeutics. 109(1). 184–192. 3 indexed citations

Heit, Antje, Frank Schmitz, Britta Flach, et al.. (2017). Vaccination establishes clonal relatives of germinal center T cells in the blood of humans. The Journal of Experimental Medicine. 214(7). 2139–2152. 83 indexed citations

Froeschl, Guenter, Nyanda Elias Ntinginya, Chacha Mangu, et al.. (2016). Integrating Local, National, and International Stakeholders in Outbreak Preparedness in Developing Countries: Conclusions from a Conference in Mbeya, Tanzania. Health Security. 14(1). 29–34. 1 indexed citations

10.

Flach, Britta, et al.. (2016). The small noncoding RNAs (sncRNAs) of murine gammaherpesvirus 68 (MHV-68) are involved in regulating the latent-to-lytic switch in vivo. Scientific Reports. 6(1). 32128–32128. 8 indexed citations

11.

Flach, Britta, Prossy Naluyima, Kim Blom, et al.. (2013). Differential Loss of Invariant Natural Killer T Cells and FoxP3+ Regulatory T Cells in HIV-1 Subtype A and Subtype D Infections. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(3). 289–293. 4 indexed citations

12.

Flach, Britta, Leigh Anne Eller, Michael A. Eller, et al.. (2011). B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses. PLoS ONE. 6(8). e22653–e22653. 4 indexed citations

13.

Flach, Britta, et al.. (2009). The M10 Locus of Murine Gammaherpesvirus 68 Contributes to both the Lytic and the Latent Phases of Infection. Journal of Virology. 83(16). 8163–8172. 13 indexed citations

14.

Flach, Britta, et al.. (2008). In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences. Virology. 380(2). 322–327. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact